Suppr超能文献

用于再生梗死心肌的工程化免疫调节生物材料。

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium.

作者信息

Bloise Nora, Rountree Isobel, Polucha Collin, Montagna Giulia, Visai Livia, Coulombe Kareen L K, Munarin Fabiola

机构信息

Department of Molecular Medicine, Center for Health Technologies (CHT), INSTM UdR of Pavia, University of Pavia, Pavia, Italy.

Department of Occupational Medicine, Toxicology and Environmental Risks, ICS Maugeri, IRCCS, Pavia, Italy.

出版信息

Front Bioeng Biotechnol. 2020 Apr 7;8:292. doi: 10.3389/fbioe.2020.00292. eCollection 2020.

Abstract

Coronary artery disease is a severe ischemic condition characterized by the reduction of blood flow in the arteries of the heart that results in the dysfunction and death of cardiac tissue. Despite research over several decades on how to reduce long-term complications and promote angiogenesis in the infarct, the medical field has yet to define effective treatments for inducing revascularization in the ischemic tissue. With this work, we have developed functional biomaterials for the controlled release of immunomodulatory cytokines to direct immune cell fate for controlling wound healing in the ischemic myocardium. The reparative effects of colony-stimulating factor (CSF-1), and anti-inflammatory interleukins 4/6/13 (IL4/6/13) have been evaluated and in a predictive model of ischemia (the skin flap model) to optimize a new immunomodulatory biomaterial that we use for treating infarcted rat hearts. Alginate hydrogels have been produced by internal gelation with calcium carbonate (CaCO) as carriers for the immunomodulatory cues, and their stability, degradation, rheological properties and release kinetics have been evaluated . CD14 positive human peripheral blood monocytes treated with the immunomodulatory biomaterials show polarization into pro-healing macrophage phenotypes. Unloaded and CSF-1/IL4 loaded alginate gel formulations have been implanted in skin flap ischemic wounds to test the safety and efficacy of the delivery system . Faster wound healing is observed with the new therapeutic treatment, compared to the wounds treated with the unloaded controls at day 14. The optimized therapy has been evaluated in a rat model of myocardial infarct (ischemia/reperfusion). Macrophage polarization toward healing phenotypes and global cardiac function measured with echocardiography and immunohistochemistry at 4 and 15 days demonstrate the therapeutic potential of the proposed immunomodulatory treatment in a clinically relevant infarct model.

摘要

冠状动脉疾病是一种严重的缺血性疾病,其特征是心脏动脉血流减少,导致心脏组织功能障碍和死亡。尽管数十年来一直在研究如何减少长期并发症并促进梗死灶的血管生成,但医学领域尚未确定诱导缺血组织血管再通的有效治疗方法。通过这项工作,我们开发了功能性生物材料,用于免疫调节细胞因子的控释,以引导免疫细胞命运,从而控制缺血心肌的伤口愈合。我们已经在缺血的预测模型(皮瓣模型)中评估了集落刺激因子(CSF-1)和抗炎白细胞介素4/6/13(IL4/6/13)的修复作用,以优化一种用于治疗梗死大鼠心脏的新型免疫调节生物材料。通过用碳酸钙(CaCO)进行内部凝胶化制备了藻酸盐水凝胶,作为免疫调节信号的载体,并评估了它们的稳定性、降解性、流变学性质和释放动力学。用免疫调节生物材料处理的CD14阳性人外周血单核细胞表现出向促愈合巨噬细胞表型的极化。将未负载和负载CSF-1/IL4的藻酸盐凝胶制剂植入皮瓣缺血伤口,以测试递送系统的安全性和有效性。与在第14天用未负载对照处理的伤口相比,新的治疗方法观察到伤口愈合更快。在心肌梗死(缺血/再灌注)大鼠模型中评估了优化后的治疗方法。在第4天和第15天通过超声心动图和免疫组织化学测量的巨噬细胞向愈合表型的极化和整体心脏功能证明了所提出的免疫调节治疗在临床相关梗死模型中的治疗潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验